The site uses anonymous third party analytic cookies: in accessing any element/area of the site outside of this banner, you consent to receiving cookies.

Knowledge Hub

Soundbites from the NHS: Access to cancer therapies – Understanding the challenges of pharmacy aseptic manufacturing units

In this new series in our ‘Soundbites from the NHS’, we speak to Rob Duncombe, Chief Pharmacist for The Royal Marsden NHS Foundation Trust for a conversation dedicated to understanding the challenges of pharmacy aseptic manufacturing units.

Watch each episode in the series chronologically by clicking the videos below:

Episode 1: The challenges of the aseptic manufacturing units

 

Episode 2: Overcoming the challenges

 

Episode 3: Capacity issues influencing treatment choices

 

Episode 4: Are treatment change decisions being made locally or by the cancer alliances?

 

Episode 4: Are treatment change decisions being made locally or by the cancer alliances?

 

Episode 5: Demonstrating the value of switching treatments

 

Episode 6: Challenges for the NHS & aseptic manufacturing units forward

 

Episode 7: Implications of the closures of aseptic manufacturing units

 

Episode 8: What can industry do to support manufacturing of cancer treatments?